Results for "nivolumab" | Prospecte.ro

Medication leaflets

OPDIVO 10mg/ml concentrate for solution for infusion BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: nivolumab

ATC code: L01FF01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Price

5765.41 RON

List

C2

Prescription

P-RF
OPDIVO 300mg solution for injection BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: nivolumab

ATC code: L01FF01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Prescription

P-RF
OPDIVO 600mg solution for injection BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: nivolumab

ATC code: L01FF01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Price

13660.22 RON

Prescription

P-RF
OPDUALAG 240mg/80mg concentrate for solution for infusion BRISTOL MYERS SQUIBB ORIGINAL MEDICINE

Chemical substance: nivolumab + relatlimab

ATC code: L01FY02 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Combinations of monoclonal antibodies and antibody drug conjugates

Price

21072.95 RON

Prescription

P-RF

Results for the substance nivolumab

nivolumab

Indicated for: cancer

L01FF01 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors
nivolumab + relatlimab

Indicated for: cancer

L01FY02 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Combinations of monoclonal antibodies and antibody drug conjugates